Feasibility & Site Selection
Data-Driven, Community-Centred Site Strategy
Data-Driven, Community-Centred Site Strategy
At Orizzonte, feasibility begins where patients already are, in primary care. By leveraging real-world data from GP practices and working with pre-qualified sites, we help sponsors and CROs select the right sites faster and more reliably.
Our Approach to Feasibility
Real-Time Patient Screening
Using EMIS and SystemOne, we assess patient populations against protocol criteria across our national GP network, providing fast, accurate feasibility data.
Practice Profiling
We evaluate sites based on clinical infrastructure, research experience, demographic reach, and capacity to deliver.
Tailored Site Matching
Each study is matched with the most appropriate practices, taking into account therapeutic focus, expected recruitment targets, and geographic diversity.
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Rapid, Reliable Site Activation
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Rapid, Reliable Site Activation
Pre-qualified practices with research readiness
Streamlined onboarding and training
Centralised coordination for contracting and document collection
Who we work with
Pharmaceuticals
Hospitals
Academia
Why It Matters
Reduced Trial Delays
Evidence-based site selection helps avoid underperforming sites and recruitment shortfalls.
Real-World Representation
Our network includes practices in urban, rural, and underserved regions, ensuring diversity in study populations.
Sponsor Confidence
Data-driven feasibility and operational readiness give sponsors the insight they need for confident site selection.
Reduced Trial Delays
Real-World Representation
Sponsor Confidence
